Issue · Criminal Justice

Criminal Justice

Every criminal justice bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
1
119th Congress
Top supporter
Alan Armstrong
86% support rate
Top opponent
Amy Klobuchar
13% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving criminal justice in United States

Legislators moving criminal justice in United States
Legislator Party Stance Support rate Votes
AA
Alan Armstrong Senate
R
Strong +
86% 44
Mitch McConnell
Mitch McConnell Senate
R
Strong +
84% 160
Kevin Cramer
Kevin Cramer Senate
R
Strong +
80% 169
Cynthia M. Lummis
Cynthia M. Lummis Senate
R
Strong +
80% 167
Mike Lee
Mike Lee Senate
R
Support
77% 170
Amy Klobuchar
Amy Klobuchar Senate
D
Strong −
13% 169
Margaret Wood Hassan
Margaret Wood Hassan Senate
D
Strong −
13% 169
Catherine Cortez Masto
Catherine Cortez Masto Senate
D
Strong −
13% 162
Brian Schatz
Brian Schatz Senate
D
Strong −
16% 171
Andy Kim
Andy Kim Senate
D
Strong −
16% 171
Showing 1 of 1 bills

All criminal justice bills

signed · United States · Senate Jul 16, 2025

S 331: HALT Fentanyl Act

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.